NEW YORK (GenomeWeb News) - In response to a delay in the closing of its Series D financing round, Complete Genomics has cut its costs, including staff salaries, GenomeWeb Daily News sister publication In Sequence reported today.

According to Cliff Reid, the company's chairman, president, and CEO, the company is in the late stages of closing a Series D investment. But as a result of the slowdown of the capital markets in recent months, "it has taken us longer than anticipated to close," he said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.